REINHARDT MAX 4
4 · Pacira BioSciences, Inc. · Filed Oct 11, 2022
Insider Transaction Report
Form 4
REINHARDT MAX
President
Transactions
- Sale
Common Stock
2022-10-07$58.00/sh−1,380$80,040→ 31,378 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.